PROCLIPI研究:蕈样肉芽肿/Sézary综合征新诊断患者生活质量显著更差的相关特征
本研究基于国际前瞻性观察性PROCLIPI研究,纳入237例新诊断的蕈样肉芽肿(MF)/Sézary综合征(SS)患者,使用Skindex-29问卷评估健康相关生活质量(HRQoL)。女性在症状和情绪子量表上的严重受损与烧灼/刺痛、瘙痒、刺激感及抑郁、羞耻、尴尬和烦恼感有关。
核心结论
- 新诊断的MF/SS女性患者及伴有脱发的患者HRQoL受损更显著。
- 现有Skindex-29未涵盖癌症相关存在性问题,亟需经验证的皮肤T细胞淋巴瘤特异性问卷。
研究设计与样本
- 使用Skindex-29问卷评估HRQoL,分析其与患者及疾病特征的关系。
主要发现
- 单因素分析显示,女性、SS、晚期MF、乳酸脱氢酶升高、脱发、高改良严重度加权评估工具评分及融合性红斑与HRQoL更差相关。
临床怎么用
- 在新诊断MF/SS患者中,应特别关注女性及伴有脱发患者的HRQoL。
- 评估HRQoL时需注意烧灼/刺痛、瘙痒、刺激感及抑郁、羞耻、尴尬等情绪问题。
局限性
- Skindex-29未包含癌症相关存在性问题,可能低估额外担忧和痛苦。
- 亟需经验证的皮肤T细胞淋巴瘤特异性问卷以更准确评估疾病特异性HRQoL。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mycosis fungoides (MF) and Sézary Syndrome (SS) are the most common cutaneous T-cell lymphomas. MF/SS is accompanied by considerable morbidity from pain, itching and disfigurement. AIM: To identify factors associated with poorer health-related quality of life (HRQoL) in patients newly diagnosed with MF/SS. METHODS: Patients enrolled into Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI; an international observational study in MF/SS) had their HRQoL assessed using the Skindex-29 questionnaire. Skindex-29 scores were analysed in relation to patient- and disease-specific characteristics. RESULTS: The study population consisted of 237 patients [60·3% male; median age 60 years, (interquartile range 49-70)], of whom 179 had early MF and 58 had advanced MF/SS. In univariate analysis, HRQoL, as measured by Skindex-29, was worse in women, SS, late-stage MF, those with elevated lactate dehydrogenase, alopecia, high modified Severity Weighted Assessment Tool and confluent erythema. Linear regression models only identified female gender (β = 8·61; P = 0·003) and alopecia (β = 9·71, P = 0·02) as independent predictors of worse global HRQoL. Item-level analysis showed that the severe impairment in symptoms [odds ratio (OR) 2·14, 95% confidence interval (CI) 1·19-3·89] and emotions (OR 1·88, 95% CI 1·09-3·27) subscale scores seen in women was caused by more burning/stinging, pruritus, irritation and greater feelings of depression, shame, embarrassment and annoyance with their diagnosis of MF/SS. CONCLUSIONS: HRQoL is significantly more impaired in newly diagnosed women with MF/SS and in those with alopecia. As Skindex-29 does not include existential questions on cancer, which may cause additional worry and distress, a comprehensive validated cutaneous T-cell lymphoma-specific questionnaire is urgently needed to more accurately assess disease-specific HRQoL in these patients. What's already known about this topic? Cross-sectional studies of mixed populations of known and newly diagnosed patients with mycosis fungoides (MF)/Sézary syndrome (SS) have shown significant impairment in health-related quality of life (HRQoL). Previous studies on assessing gender-specific differences in HRQoL in MF/SS are conflicting. More advanced-stage disease and pruritus is associated with poorer HRQoL in patients with MF/SS. What does this study add? This is the first prospective study to investigate HRQoL in a homogenous group of newly diagnosed patients with MF/SS. In patients newly diagnosed with MF/SS, HRQoL is worse in women and in those with alopecia and confluent erythema. MF/SS diagnosis has a multidimensional impact on patient HRQoL, including a large burden of cutaneous symptoms, as well as a negative impact on emotional well-being.
引用
- Molloy K, Jonak C, Woei-A-Jin FJSH, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol. 2019. PMID: 31049926. doi:10.1111/bjd.18089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。